# FDA Inspection 898617 - Alexander E. Horwitz, III, M.D. - October 02, 2014

Source: https://www.keypedia.com/records/fda_inspections/alexander-e-horwitz-iii-md/c26e2003-17bc-47bf-9c6a-f2ddec03e8ae
Source feed: FDA_Inspections

> FDA Inspection 898617 for Alexander E. Horwitz, III, M.D. on October 02, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 898617
- Company Name: Alexander E. Horwitz, III, M.D.
- Inspection Date: 2014-10-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1192948 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/alexander-e-horwitz-iii-md/85e0d39a-aed9-4a0b-b838-7d1c7c7303ba)
- [FDA Inspection 903151 - 2014-11-14](https://www.keypedia.com/records/fda_inspections/alexander-e-horwitz-iii-md/588092c3-ff5b-4618-a5c0-b7fa954c71f1)
- [FDA Inspection 813526 - 2012-12-14](https://www.keypedia.com/records/fda_inspections/alexander-e-horwitz-iii-md/a89d9528-8175-40e7-ada8-8a55c49fb5e0)

Company: https://www.keypedia.com/companies/alexander-e-horwitz-iii-md/86082505-bbcc-4f38-977e-ab37b9551fe1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c